Stock Showdown — MPTI vs CODA vs ESP vs CVU
Four defense micro-caps, each with a different flavor of moat and growth story. The question isn't which is the "best company" — it's which one deserves your capital today, at today's price.
1. At-a-Glance Snapshot
| Metric | MPTI | CODA | ESP | CVU |
|---|---|---|---|---|
| Company | M-tron Industries | Coda Octopus Group | Espey Mfg. & Electronics | CPI Aerostructures |
| What They Make | Crystal oscillators & RF filters for defense electronics | Real-time 3D underwater imaging sonar & diver displays | Ruggedized power systems for Navy submarines | Structural assemblies for military aircraft & EW pods |
| Sector | Electronic Components | Electronic Equipment | Aerospace & Defense | Aerospace & Defense |
| Market Cap | $190M | $158M | $172M | $59M |
| Enterprise Value | $172M | $130M | $128M | ~$79M |
| Price | $64.85 | $14.06 | $58.00 | $4.47 |
| 52-Week Range | $36.19 – $68.50 | $5.76 – $17.28 | $27.00 – $62.00 | $2.45 – $5.70 |
| 52-Week Performance | +80% | +144% | +115% | +50% |
| Dividend Yield | 0% | 0% | ~1.5% | 0% |
| Beta | 0.80 | 0.47 | 0.55 | 0.90 |
| Employees | ~70 | ~100 | 152 | ~212 |
2. Business Model Comparison
| Dimension | MPTI | CODA | ESP | CVU |
|---|---|---|---|---|
| Revenue Model | Design & manufacture defense components on multi-year contracts | Product sales (sonar hardware, DAVD) + engineering services | Build-to-spec OEM manufacturing on fixed-price defense contracts | Contract manufacturing on fixed-price & cost-plus defense contracts |
| Revenue Mix | Oscillators (~60%) / RF filters (~35%) / Integrated assemblies (~5%) | Marine Tech (~50%) / Defense Engineering (~30%) / Acoustics (~20%) | Military power systems (~80%) / Industrial (~20%) | Defense aerostructures (~65%) / EW pods (~15%) / Commercial (~20%) |
| Geographic Mix | ~95% domestic | Global (U.S., Europe, Aus, Asia, ME) | ~90% domestic | ~100% domestic |
| Customer Concentration | High (top 3 primes = ~35-40%) | High (U.S. Navy dominant) | Very High (6 customers = 74%) | High (Raytheon = largest, growing) |
| Competitive Moat | Qualification barriers + regulatory (ITAR) — Strong | Technology monopoly (sole real-time 3D sonar) — Strong | Designed-in on submarine programs + switching costs — Strong | Program lock-in + certifications — Moderate |
| TAM | $500M–$800M (U.S. mil-spec frequency/RF) | $300M–$500M (advanced imaging sonar + diver tech) | $3B–$5B (U.S. military power electronics) | $15B+ (global aerostructures, but CPI's SAM is smaller) |
| Secular Tailwinds | Defense spending, EW proliferation, domestic sourcing mandates | AUV revolution, diver modernization, offshore wind | Columbia-class submarine, naval electrification | Defense spending, NGJ-MB production, F-16 exports |
Business Model Takeaway
Most durable business model: ESP. Being designed into the Columbia-class submarine program — the U.S. Navy's #1 acquisition priority, a $130B program building 12 submarines through 2042 — creates the closest thing to a guaranteed revenue stream in defense. You literally cannot un-design Espey's power distribution panels from a nuclear submarine that's already under construction.
Largest growth runway: CODA. Real-time 3D sonar for autonomous underwater vehicles is a greenfield market that doesn't fully exist yet. If the underwater drone revolution materializes like the aerial drone revolution did, CODA's Echoscope technology becomes the standard perception sensor. The TAM could expand 5-10x over the next decade.
Business model red flag: CVU's build-to-print model has the weakest moat of the four. While program lock-in provides near-term protection, CPI doesn't own proprietary technology — they're a manufacturing services provider. Margins are structurally lower (15-22% gross vs. 35-66% for the others), and the SEC restatement history, while resolved, leaves a governance scar.
3. Financial Health — Side by Side
Income Statement
| Metric | MPTI | CODA | ESP | CVU |
|---|---|---|---|---|
| Revenue (TTM) | $53.0M | $26.6M | $44.0M | ~$80M |
| Revenue Growth (YoY) | +12% | +31% | +11% | ~flat (A-10 drag) |
| Revenue Growth (3Y CAGR) | ~19% | ~11% | ~15% | ~5% |
| Gross Margin | 43.5% (9M'25) | 66.5% | 34.4% (LTM) | ~18% (normalized 20-22%) |
| Operating Margin | ~17% | 17.1% | ~22% (LTM) | ~5% (normalized 7-9%) |
| Net Margin | ~13% | 15.5% | ~20% (LTM) | ~2% (normalized 5-6%) |
| EPS (TTM) | $2.40 | $0.37 | $3.46 | ~$0.15 |
| EPS (NTM est.) | ~$2.55 | ~$0.48 | ~$4.80 | ~$0.40+ |
Cash Flow & Balance Sheet
| Metric | MPTI | CODA | ESP | CVU |
|---|---|---|---|---|
| FCF (TTM) | ~$6.2M | $6.0M | $11.7M | ~$2M |
| FCF Margin | ~12% | 22.7% | ~27% | ~2.5% |
| FCF Yield | 3.3% | 3.8% | 6.8% | ~3.4% |
| Net Cash / (Debt) | $18.3M cash | $28.7M cash | $17.8M cash | ~($15M) debt |
| Net Debt / EBITDA | Net cash | Net cash | Net cash | ~2.0x |
| Cash & Equivalents | $18.3M | $28.7M | $17.8M | ~$3M |
| Backlog | $58.8M | N/A (order-driven) | $134.7M | $510M |
Financial Health Ranking
- ESP — Zero debt, $17.8M cash, 27% FCF margin, expanding margins, $134.7M backlog. The healthiest financial profile in the group by a clear margin.
- CODA — Cash exceeds annual revenue ($28.7M vs $26.6M), zero debt, 66.5% gross margins. Fortress balance sheet, though FCF is smaller in absolute terms.
- MPTI — Zero debt, $18.3M cash, strong ROIC. Margin compression in 2025 is the one blemish.
- CVU — The only company with debt ($15M). Lowest margins, thinnest cash position. The A-10 writeoff temporarily distorted earnings. Getting better but clearly the weakest financial profile.
4. Growth Comparison
| Metric | MPTI | CODA | ESP | CVU |
|---|---|---|---|---|
| Backlog | $58.8M (1.1x rev) | N/A | $134.7M (3.1x rev) | $510M (6.4x rev) |
| Revenue CAGR (3Y hist.) | ~19% | ~11% | ~15% | ~5% |
| Revenue Growth (NTM est.) | ~12-15% | ~15-20% | ~15-20% | ~10-15% |
| R&D as % Revenue | Not disclosed (in SG&A) | 9.0% | Not disclosed | Minimal |
| Recent M&A | None (but actively pursuing) | Precision Acoustics ($4.6M, Oct 2024) | None | None |
Growth Catalysts (Next 12-24 Months)
MPTI:
- First M&A deal — CEO was hired specifically for this
- Gross margin recovery from tariff-induced compression
- Multi-domain data link contract ramp (program through 2036)
CODA:
- DAVD/DUS fleet-wide adoption after Authorization for Navy Use
- Echoscope NANO uptake for autonomous underwater vehicles
- International defense expansion (European navy adoption)
ESP:
- Columbia-class production ramp reaching peak delivery cadence
- New $7.4M Navy-funded Magnetics Center of Excellence driving capacity
- Continued margin expansion from operating leverage on fixed-cost base
CVU:
- NGJ-MB pod production ramp (largest growth driver)
- Clean quarterly earnings in FY2026 (no A-10 writeoff drag)
- F-16 Block 70/72 international orders flowing through
Growth Ranking
| Rank | Ticker | Current Momentum | Forward Runway |
|---|---|---|---|
| 1 | CODA | Strong (+31% YoY) | Largest (AUV market is greenfield) |
| 2 | ESP | Strong (+11% with margin expansion) | Very deep ($134.7M backlog, Columbia through 2042) |
| 3 | MPTI | Solid (+12% but margins compressing) | Good (backlog + M&A optionality) |
| 4 | CVU | Weak (A-10 drag, flat revenue) | Good ($510M backlog, but conversion is the question) |
5. Valuation Comparison
Absolute Multiples
| Multiple | MPTI | CODA | ESP | CVU |
|---|---|---|---|---|
| P/E (TTM) | 27.0x | 38.2x | 16.8x | N/M (depressed) |
| P/E (NTM) | 25.5x | 27.6x | ~12.1x | ~11x |
| EV/EBITDA (TTM) | 17.1x | ~21x | 12.9x | ~10x |
| EV/Revenue (TTM) | 3.2x | 4.9x | 2.9x | ~1.0x |
| P/FCF | 26.5x | 26.3x | 14.7x | ~30x |
| P/B | 5.1x | 2.7x | 2.8x | ~2.3x |
Growth-Adjusted Valuation
| Stock | NTM P/E | EPS Growth (NTM) | PEG | Verdict |
|---|---|---|---|---|
| MPTI | 25.5x | ~6% | 4.3x | Expensive — PEG above 2x with growth decelerating |
| CODA | 27.6x | ~30% | 0.9x | Fair — high multiple justified by growth rate |
| ESP | 12.1x | ~39% | 0.3x | Cheap — significant margin expansion driving EPS growth |
| CVU | ~11x | ~150%+ (off depressed base) | <0.1x | Cheap — but base effect distorts; normalized PEG ~1.0x |
Valuation Ranking (Growth-Adjusted)
- ESP — Cheapest stock in the group on every metric. 12x forward earnings with 39% EPS growth, 3.1x backlog coverage, and margin expansion ahead. The market hasn't fully priced in the operating leverage story.
- CVU — Optically cheap at $4.47, but you're buying a turnaround, not a compounder. The $510M backlog is impressive but margin normalization is the key bet.
- CODA — Expensive on TTM (38x P/E) but reasonable on a PEG basis (0.9x) if 30% growth sustains. The technology monopoly justifies a premium.
- MPTI — Most expensive stock in the group. 25x forward with decelerating growth and margin compression. The premium requires margin recovery and M&A execution to justify.
6. Quality & Capital Allocation
| Metric | MPTI | CODA | ESP | CVU |
|---|---|---|---|---|
| ROIC | 34.87% | ~7-13% | ~25%+ | ~8% (normalized) |
| ROE | 22.7% | ~7.1% | ~20% | ~5% |
| ROIC vs. WACC | Creating (4x WACC) | Creating (modestly) | Creating (3x WACC) | Marginal |
| Insider Ownership | 9.5% | 45% | ~15%+ | 21% |
| Recent Insider Activity | Warrant exercises only | Sondergaard selling | Chairman buying, CEO selling | Chairman buying, no selling |
| Dividend | None | None | ~1.5% yield | None |
| Cap Alloc Grade | B | B | B+ | B- |
Quality Ranking
- MPTI — Highest ROIC (35%), strongest value creation per dollar invested. The frequency control moat is deep and durable.
- ESP — Excellent ROIC (~25%), expanding margins, chairman buying on open market ($17M+ position). Defense program lock-in is extremely sticky.
- CODA — Technology monopoly is genuine, but ROIC is mediocre (~7-13%) because the company is sitting on a massive cash pile ($28.7M) that's not being deployed productively. The 45% insider ownership is the highest alignment in the group.
- CVU — Lowest quality metrics. Narrow moat (build-to-print), SEC restatement history, lowest margins. The turnaround is real but quality is objectively lower than the other three.
7. Risk Comparison
| Risk Dimension | MPTI | CODA | ESP | CVU |
|---|---|---|---|---|
| Cyclicality | Low | Low | Low | Moderate |
| Customer Concentration | High | High | Very High | High |
| Regulatory Risk | Low | Low | Low | Moderate (SEC history) |
| Leverage Risk | None (net cash) | None (net cash) | None (net cash) | Moderate ($15M debt) |
| Key-Person Risk | Moderate (CEO dual role) | Moderate (CEO/Chairman) | Low (deep bench) | Low (CEO proven) |
| Competitive Disruption | Low (near-term) | Low (no competitor) | Very Low | Moderate (build-to-print replaceable) |
| Macro Sensitivity | Low | Low | Very Low | Moderate |
| Valuation Risk | High (27x P/E, margins compressing) | High (38x P/E, near highs) | Low (12x P/E, margin expansion) | Low ($4.47, turnaround entry) |
Top Risk Per Stock
- MPTI: Margin compression proves structural. If gross margins stay at 43% instead of recovering to 46%, the stock is 20%+ overvalued.
- CODA: Valuation. At 38x trailing P/E near its 52-week high, any earnings miss sends the stock down 20-30%. Q1 earnings are March 17 — two days away.
- ESP: Single-facility risk. Everything happens in one building in Saratoga Springs. A fire, flood, or major equipment failure could halt all production.
- CVU: Execution risk on backlog conversion. A $510M backlog means nothing if the company can't convert it to revenue at normalized margins. The A-10 writeoff showed things can go wrong.
8. Technical Setup
| Dimension | MPTI | CODA | ESP | CVU |
|---|---|---|---|---|
| Trend | Above both MAs (uptrend) | Above both MAs (strong uptrend) | Above both MAs (uptrend) | Above 50d, near 200d |
| RSI | Neutral (~55-65) | Elevated (~65-70) | Neutral (~55) | Neutral (~50) |
| Distance from 52W High | -5% | -19% | -6% | -22% |
| Volume Trend | Thin, neutral | Accumulation | Thin, neutral | Thin, neutral |
| Near-Term Setup | Neutral (earnings Mar 26) | Unfavorable (earnings Mar 17, extended) | Favorable (consolidating near highs) | Favorable (basing pattern near $4.50) |
Technical Verdict
- Best entry timing now: CVU (basing near $4.50, 22% below highs, turnaround catalyst ahead) and ESP (consolidating near highs with margin expansion continuing)
- Wait for better entry: CODA (extended run, earnings imminent on Mar 17) and MPTI (near highs with earnings on Mar 26 — margin data is critical)
9. Composite Scorecard
| Dimension | Weight | MPTI | CODA | ESP | CVU |
|---|---|---|---|---|---|
| Business Quality | 20% | 4.5/5 | 4.5/5 | 4.0/5 | 3.0/5 |
| Financial Health | 15% | 4.0/5 | 4.5/5 | 5.0/5 | 2.5/5 |
| Growth | 20% | 3.5/5 | 4.5/5 | 4.0/5 | 3.5/5 |
| Valuation | 20% | 2.0/5 | 2.5/5 | 4.5/5 | 4.0/5 |
| Quality & Cap Alloc | 10% | 4.5/5 | 3.0/5 | 4.0/5 | 2.5/5 |
| Risk (inverted) | 10% | 3.0/5 | 3.0/5 | 3.5/5 | 2.5/5 |
| Technical Timing | 5% | 2.5/5 | 2.0/5 | 4.0/5 | 3.5/5 |
| Weighted Score | 100% | 3.36 | 3.50 | 4.21 | 3.14 |
10. Final Verdict
Ranking
| Rank | Ticker | Score | Verdict | One-Line Rationale |
|---|---|---|---|---|
| 1 | ESP | 4.21 | BUY | Cheapest stock (12x forward P/E) with the deepest backlog visibility ($134.7M), expanding margins, zero debt, and a chairman who bought $17M+ on the open market. Best risk/reward in the group. |
| 2 | CODA | 3.50 | WATCH | Genuine technology monopoly with 66% gross margins, but 38x trailing P/E near all-time highs with earnings 2 days away is not the time to chase. Wait for a post-earnings pullback to $11-13. |
| 3 | MPTI | 3.36 | WATCH | High-quality business with a deep moat, but margin compression + premium valuation (27x P/E) means risk/reward is unfavorable until Q4 earnings (Mar 26) confirm margin recovery. |
| 4 | CVU | 3.14 | SPECULATIVE BUY | Cheapest on absolute price ($4.47) with the biggest backlog ($510M), but lowest quality (narrow moat, SEC history, debt, low margins). A turnaround bet for those with higher risk tolerance. |
If You Can Only Buy One
Buy ESP. It's the only stock in this group where the valuation (12x forward P/E), the growth trajectory (39% EPS growth), the balance sheet (net cash), and the backlog depth ($134.7M, 3x revenue) are all working in your favor simultaneously. The Columbia-class submarine program is the U.S. Navy's top acquisition priority — it doesn't get cut, delayed, or defunded. That's the kind of revenue visibility that lets you sleep at night with a micro-cap position.
The chairman personally bought $17M+ of stock on the open market. When the person who runs the board is writing checks that large, you pay attention. ESP is the only stock in this group where the biggest insider signal is a massive open-market purchase rather than routine warrant exercises or no activity at all.
If You Want Diversification
Buy ESP (3%) + CVU (1.5%) + CODA on pullback (2%).
This gives you three different defense niches — submarine power electronics, aerostructures/EW pods, and underwater sonar — with different risk profiles and growth drivers. ESP is the core holding (highest conviction, best risk/reward). CVU is the speculative kicker (lowest price, biggest backlog, highest upside if turnaround executes). CODA adds a technology monopoly with the longest growth runway once you get a better entry price.
Skip MPTI for now — it's the most expensive stock in the group on a growth-adjusted basis, and you get similar defense electronics exposure with better risk/reward through ESP.
Stock showdown compiled March 15, 2026. All prices as of March 13 close. Next catalysts: CODA Q1 FY2026 earnings (March 17), MPTI Q4 FY2025 earnings (March 26).